Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma

Maryam B. Lustberg, Tanios Bekaii-Saab, Donn Young, Gregory Otterson, William Burak, Abbas Abbas, Barbara McCracken-Bussa, Mark E. Lustberg, Miguel A. Villalona-Calero

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Fingerprint Dive into the research topics of 'Phase II randomized study of two regimens of sequentially administered mitomycin C and irinotecan in patients with unresectable esophageal and gastroesophageal adenocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences